Australia's ALS to see continued slowdown in commodities business - Morningstar
29/09/2023 03:54
** Analysts at Morningstar expect a continuing slowdown in
the commodities business for Australia's laboratory services
provider ALS ALQ.AX
** Maintains fair value estimate of A$8.40/share for ALS
** Near-term market dynamics have not significantly changed
to warrant an update to our forecasts - Morningstar
** ALS shares currently up 0.5%
** Five of nine analysts rate the stock "buy" or higher and
four "hold"; their median PT is A$12.90 – LSEG data
** Stock has fallen 6.7% this year, as of last close
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))
Recent news on ALS
See all newsAustralia's ALS jumps as brokerages raise earnings estimate on commodities boost
Brokerages raise earnings estimate for Australia's ALS on commodities boost
Australia's ALS jumps on higher annual profit
Brief: Als Ltd Targeting Mid To High Single-Digit Organic Rev Growth Across Group For Fy27
Brief: ALS Ltd Posts Net Income Attributable AUD 318.7 Million